Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    
        
        Lancet Diabet. Endocrinol. 6, 249-258 (2017)
    
    
    
				Obesity increases the risk of several other chronic diseases and, because of its epidemic proportions, has become a major public health problem worldwide. Alarmingly, a lower proportion of adults have tried to lose weight during the past decade than during the mid-1980s to 1990s. The first-line treatment option for obesity is lifestyle intervention. Although this approach can decrease fat mass in the short term, these beneficial effects typically do not persist. If a large amount of weight loss is not an easily achievable goal, other goals that might motivate people with obesity to adopt a healthy lifestyle should be considered. In this setting, the concept of metabolically healthy obesity is useful. Accumulating evidence suggests that, although the risk of all-cause mortality and cardiovascular events might be higher in people with metabolically healthy obesity compared with metabolically healthy people of a normal weight, the risk is substantially lower than in individuals with metabolically unhealthy obesity. Therefore, every person with obesity should be motivated to achieve a normal weight in the long term, but more moderate weight loss sufficient for the transition from metabolically unhealthy obesity to metabolically healthy obesity might also lower the risk of adverse outcomes. However, how much weight needs to be lost for this transition to occur is under debate. This transition might be supported by lifestyle factors-such as the Mediterranean diet-that affect cardiovascular risk, independent of body fat. In this Series paper, we summarise available information about the concept of metabolically healthy obesity, highlight gaps in research, and discuss how this concept can be implemented in clinical care.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				19.742
					4.507
					35
					151
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Life-style Intervention; Type-2 Diabetes-mellitus; Body-mass Index; Cardiovascular-disease Outcomes; Randomized Controlled-trials; Unhealthy Normal-weight; Low-fat Diets; Mediterranean Diet; Bariatric Surgery; Risk-factors
    
 
     
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2017
    
 
     
    
        HGF-Berichtsjahr
        2017
    
 
    
    
        ISSN (print) / ISBN
        2213-8587
    
 
    
        e-ISSN
        2213-8595
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Lancet Diabetes and Endocrinology
    
 
		
    
        Quellenangaben
        
	    Band: 6,  
	    Heft: 3,  
	    Seiten: 249-258 
	    
	    
	
    
 
  
         
        
            Verlag
            Elsevier
        
 
        
            Verlagsort
            New York
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        90000 - German Center for Diabetes Research
    
 
    
        Forschungsfeld(er)
        Helmholtz Diabetes Center
    
 
    
        PSP-Element(e)
        G-502400-002
    
 
     
     	
    
    
        WOS ID
        WOS:000425719400023
    
    
        Scopus ID
        85029420029
    
    
        PubMed ID
        28919065
    
    
        Erfassungsdatum
        2017-09-26